Helius Medical Technologies, Inc.

NASDAQ (USD): Helius Medical Technologies, Inc. (HSDT)

Last Price

1.03

Today's Change

+0.279 (37.15%)

Day's Change

0.883 - 1.60

Trading Volume

108,333,387

Profile
HSDT

Exchange:  NASDAQ Capital Market NASDAQ Capital Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Dane Carl Andreeff Mr. Dane Carl Andreeff

Full Time Employees:  22 22

IPO Date:  2014-06-27 2014-06-27

CIK:  0001610853 0001610853

ISIN:  US42328V8019 US42328V8019

CUSIP:  42328V504 42328V504

Beta:  1.61 1.61

Last Dividend:  0.00 0.00

Dcf Diff:  -0.16 -0.16

Dcf:  1.07 1.07

Description

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

Address

642 Newtown Yardley Road,
Newtown, PA 18940, US

215 944 6100

http://heliusmedical.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment